
Mary Mosher
Examiner (ID: 8389)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1813, 1815, 1643, 2899, 1648, 1641, 1804, 1609, 1805 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9503000
[patent_doc_number] => 08741311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Methods and compositions for immunization against virus'
[patent_app_type] => utility
[patent_app_number] => 12/748265
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28688
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12748265
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748265 | Methods and compositions for immunization against virus | Mar 25, 2010 | Issued |
Array
(
[id] => 6070126
[patent_doc_number] => 20110044976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'HUMANIZED ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/748304
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17521
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12748304
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748304 | Humanized antibodies | Mar 25, 2010 | Issued |
Array
(
[id] => 6007455
[patent_doc_number] => 20110059486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'NON-SPLICING VARIANTS OF GP350/220'
[patent_app_type] => utility
[patent_app_number] => 12/716806
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10319
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059486.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716806 | NON-SPLICING VARIANTS OF GP350/220 | Mar 2, 2010 | Abandoned |
Array
(
[id] => 6344158
[patent_doc_number] => 20100330183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 12/714832
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5445
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12714832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714832 | SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY | Feb 28, 2010 | Abandoned |
Array
(
[id] => 9849997
[patent_doc_number] => 08951723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Serological screening for HHV-8 infection using antigen mixtures'
[patent_app_type] => utility
[patent_app_number] => 13/201317
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11449
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201317
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201317 | Serological screening for HHV-8 infection using antigen mixtures | Feb 11, 2010 | Issued |
Array
(
[id] => 8858141
[patent_doc_number] => 08460674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'HSV-1 epitopes and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 12/702218
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14462
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12702218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/702218 | HSV-1 epitopes and methods for using same | Feb 7, 2010 | Issued |
Array
(
[id] => 7754640
[patent_doc_number] => 20120027777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'LJUNGAN VIRUS WITH IMPROVED REPLICATION CHARACTERISTICS'
[patent_app_type] => utility
[patent_app_number] => 13/145871
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11738
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027777.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145871
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145871 | LJUNGAN VIRUS WITH IMPROVED REPLICATION CHARACTERISTICS | Jan 21, 2010 | Abandoned |
Array
(
[id] => 6328413
[patent_doc_number] => 20100197771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'INFLUENZA VIRUS VACCINE COMPOSITION AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/688614
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 60528
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197771.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688614
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688614 | INFLUENZA VIRUS VACCINE COMPOSITION AND METHODS OF USE | Jan 14, 2010 | Abandoned |
Array
(
[id] => 9495994
[patent_doc_number] => 08734806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Immunogenic composition and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/140893
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 9559
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140893
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140893 | Immunogenic composition and use thereof | Dec 22, 2009 | Issued |
Array
(
[id] => 7650880
[patent_doc_number] => 20110300149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'LJUNGAN VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/141758
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10662
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300149.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141758
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141758 | LJUNGAN VIRUS | Dec 22, 2009 | Abandoned |
Array
(
[id] => 6229573
[patent_doc_number] => 20100184015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHOD FOR DETECTION OF XMRV'
[patent_app_type] => utility
[patent_app_number] => 12/645181
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12574
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184015.pdf
[firstpage_image] =>[orig_patent_app_number] => 12645181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/645181 | METHOD FOR DETECTION OF XMRV | Dec 21, 2009 | Abandoned |
Array
(
[id] => 7755708
[patent_doc_number] => 20120028336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Single Recombination System and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/141595
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9873
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028336.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141595
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141595 | Single recombination system and methods of use | Dec 15, 2009 | Issued |
Array
(
[id] => 6436050
[patent_doc_number] => 20100143889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'RHABDOVIRIDAE VIRUS PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/628789
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8012
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12628789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628789 | RHABDOVIRIDAE VIRUS PREPARATIONS | Nov 30, 2009 | Abandoned |
Array
(
[id] => 4624068
[patent_doc_number] => 08003363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/622474
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 18227
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003363.pdf
[firstpage_image] =>[orig_patent_app_number] => 12622474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/622474 | Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines | Nov 19, 2009 | Issued |
Array
(
[id] => 4624069
[patent_doc_number] => 08003364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Purification of vaccinia viruses using hydrophobic interaction chromatography'
[patent_app_type] => utility
[patent_app_number] => 12/622563
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18205
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003364.pdf
[firstpage_image] =>[orig_patent_app_number] => 12622563
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/622563 | Purification of vaccinia viruses using hydrophobic interaction chromatography | Nov 19, 2009 | Issued |
Array
(
[id] => 6420785
[patent_doc_number] => 20100150959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'PCV 2-Based Methods and Compositions for the Treatment of Pigs'
[patent_app_type] => utility
[patent_app_number] => 12/621607
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10628
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20100150959.pdf
[firstpage_image] =>[orig_patent_app_number] => 12621607
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/621607 | PCV 2-Based Methods and Compositions for the Treatment of Pigs | Nov 18, 2009 | Abandoned |
Array
(
[id] => 6544575
[patent_doc_number] => 20100125129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-20
[patent_title] => 'Thermostable Fusion Proteins and Thermostable Adjuvant'
[patent_app_type] => utility
[patent_app_number] => 12/621960
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6867
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20100125129.pdf
[firstpage_image] =>[orig_patent_app_number] => 12621960
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/621960 | Thermostable Fusion Proteins and Thermostable Adjuvant | Nov 18, 2009 | Abandoned |
Array
(
[id] => 7499273
[patent_doc_number] => 20110262394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'DNA CONSTRUCTS ELICITING IMMUNE RESPONSE AGAINST FLAVIVIRUS AND EFFECTIVE ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 13/129599
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12587
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262394.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129599 | DNA constructs eliciting immune response against flavivirus and effective adjuvants | Nov 16, 2009 | Issued |
Array
(
[id] => 6431551
[patent_doc_number] => 20100143409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Generation of virus-like particles and use as panfilovirus vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/590368
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21499
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143409.pdf
[firstpage_image] =>[orig_patent_app_number] => 12590368
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/590368 | Generation of virus-like particles and use as panfilovirus vaccines | Nov 5, 2009 | Abandoned |
Array
(
[id] => 6245844
[patent_doc_number] => 20100136051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus'
[patent_app_type] => utility
[patent_app_number] => 12/611183
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11235
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136051.pdf
[firstpage_image] =>[orig_patent_app_number] => 12611183
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/611183 | N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus | Nov 2, 2009 | Abandoned |